Assessing the Association of Formulary Copayment Changes with Real-World Treatment Patterns in Patients with Rheumatoid Arthritis on Etanercept

BACKGROUND: Rheumatoid arthritis (RA) is a chronic disease that requires long-term treatment to improve or maintain stable disease activity. Tumor necrosis factor inhibitors (TNFi), a class of biologic disease-modifying antirheumatic drugs (bDMARD), are effective at treating symptoms and inhibiting...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonafede, Machaon, Oko-osi, Hafiz, Gharaibeh, Mahdi, Manjelievskaia, Janna, Lopez-Gonzalez, Lorena, Collier, David H., Stolshek, Bradley S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391095/
https://www.ncbi.nlm.nih.gov/pubmed/31823689
http://dx.doi.org/10.18553/jmcp.2019.19231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391095/
https://www.ncbi.nlm.nih.gov/pubmed/31823689
http://dx.doi.org/10.18553/jmcp.2019.19231

Ejemplares similares